MELBOURNE, Australia and INDIANAPOLIS, July 21, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market…
Latest leadership appointments reinforce Granicus’ commitment to "growth, innovation and customer success" across Australia and New Zealand MELBOURNE, Australia, July…
• First patient dosed in Phase 3 LUTEON[1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma…
MELBOURNE, Australia, July 20, 2026 /PRNewswire/ – Ascentium, a leading global business services platform headquartered in Singapore, today announced that MGI…
Internationally acclaimed Chocolatier to lead Callebaut’s renewed engagement with the chocolate and pastry community across Australia and New Zealand MELBOURNE,…
Rapid global adoption fuels fivefold valuation growth, taking total funding to $230 million as users build over 12 million applications…
MELBOURNE, Australia, July 17, 2026 /PRNewswire/ — AGIBOT, a global leader in embodied AI and robotics, hosted the Australia and…
Highlights Dimerix acquires Phase 2-ready asset, DMX-652 – with potential for rapid advancement into a Phase 2 clinical study under…
250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in…
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. The…
